Global High Content Screening Market Size study, By Product (Instruments, Consumables, Software, Services, Accessories), By Application (Target Identification and Validation, Primary Screening and Secondary Screening, Toxicity Studies, Compound Profiling, Other Applications), By End User (Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations (CROs)), and Regional Forecasts 2022-2028Global High Content Screening Market is valued approximately USD 824.58 million in 2021 and is anticipated to grow with a healthy growth rate of more than 10.3% over the forecast period 2022-2028.
High-content screening is also known commonly as cell omics or high-content analysis. It is a procedure that is majorly used to detect substances such as RNAi, peptides, or small molecules, which modifies a cell's phenotype in an ideal way during drug discovery and biological research. In this method, cells are initially created with the substance and after a point of time, measures, and molecular components of the cells are analyzed. The growing public and private investments in emerging markets, rising developments in informatics solutions and imaging instruments, availability of government funding, coupled with the thriving growth of the pharmaceutical sector are the primary factors that are stimulating the global market growth. For instance, as per India Brand Equity Foundation, 2018, the Indian government intended to invest USD 640 million in funds for increasing the drug discovery and pharmaceutical infrastructure. The initiative ‘Pharma Vision 2020’ of the Indian Government aimed to create India as a leading hub for drug discovery. Thereby, rising government investments for the drug discovery and development of the pharmaceutical sector are surging the market demand. However, high prices of HCS instruments and lack of knowledge, and shortage of skilled operators of HCS instruments impede the growth of the market over the forecast period of 2022-2028. Also, the increasing number of CROs providing HCS services and rising application of HCS in personalized medicine is anticipated to act as a catalyzing factor for the market demand during the forecast period.
The key regions considered for the global High Content Screening market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the region's developments of novel technologies, and R&D expenditure. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the increasing number of government initiatives, and rising investments in research activities for drug discovery would create lucrative growth prospects for the High Content Screening market across the Asia-Pacific region.
Major market players included in this report are:
GE Healthcare
Danaher Corporation
Thermo Fisher Scientific, Inc.
PerkinElmer, Inc.
Tecan Group
BioTek Instruments Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories Inc.
Yokogawa Electric Corporation
Merck Millipore
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product
Instruments
Consumables
Software
Services
Accessories
By Application
Target Identification and Validation
Primary Screening and Secondary Screening
Toxicity Studies
Compound Profiling
Other Applications
By End User
Pharmaceutical and Biotechnology Companies
Academic and Government Institutes
Contract Research Organizations (CROs)
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global High Content Screening Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Companies Mentioned
GE Healthcare
Danaher Corporation
Thermo Fisher Scientific, Inc.
PerkinElmer, Inc.
Tecan Group
BioTek Instruments Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories Inc.
Yokogawa Electric Corporation
Merck Millipore
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook